PTGS1 and ovarian neoplasm: (2003) reported that COX-1 and pro-angiogenic proteins were overexpressed in ovarian tumors and treatment with COX-1 inhibitor SC-560 but not COX-2 inhibitor celecoxib lead to a decrease in secretion of VEGF by OVCAR-3 cells in vitro.